Regeneration material of dermis substitution for tissue engineering skin for loading rhGM-CSF and preparation method thereof
A tissue-engineered skin and substitute technology, applied in the field of artificial dermis substitute regeneration material and its preparation, can solve the problems of easy degradation, unstable cytokine activity, etc., to accelerate the process of vascularization, reduce the risk of infection, and reduce scarring. proliferative effect
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2011-05-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a regenerative material for an artificial leather substitute and a preparation method thereof. Background technique
[0002] As the largest organ of the human body, skin is mainly composed of epidermis, dermis and subcutaneous tissue, and is also rich in blood vessels and nerves. Skin defects are easily caused in daily work and life due to various reasons such as trauma, burns, chronic diseases, surgery, etc. Although the skin tissue has a strong regenerative ability, in the case of a large area of full-thickness skin defect, due to the loss of the dermis, the regenerative ability of the skin is significantly weakened, and a large number of scars or scar contractures are easily produced.
[0003] The key to treating full-thickness skin defects is to rebuild and regenerate dermal tissue, promote early wound closure, and avoid microbial invasion. At present, there are three main ways to deal with tissue defects, namely: autol...
Examples
Embodiment 2
[0036] Collagen and chitosan were made into 0.5% acetic acid solution with a mass fraction of 0.5%, and then the collagen solution and chitosan solution were mixed according to the volume ratio of 9:1, fully stirred evenly, and injected into a mold with a diameter of 2 cm to make it After the height reaches 1.5mm, place it at 4°C for 24 hours, freeze it at -20°C for 24 hours, and then place it in a lyophilizer for 16 hours; freeze-dried scaffolds are cross-linked under vacuum at 105°C for 24 hours; Heparin was added to 0.05M MES (pH5.4) of EDC (20mmmol) and N-hydroxysuccinimide (NHS) at a molar ratio of 2:1 based on a heparin-to-collagen mass ratio of 1:10 solution, and then place the lyophilized scaffold in the mixed solution for cross-linking for 24 hours, and then freeze-lyophilize again after repeated washing to obtain a cross-linked heparinized collagen-chitosan scaffold (for microstructure, see figure 1 ).
[0037] After the heparinized collagen-chitosan scaffold was st...
Embodiment 3
[0039] Collagen and chitosan were made into 0.5% acetic acid solution with a mass fraction of 0.5%, and then the collagen solution and chitosan solution were mixed according to the volume ratio of 9:1, fully stirred evenly, and injected into a mold with a diameter of 2 cm to make it When the height reaches 1.5mm, place it at 4°C for 24 hours, freeze it at -20°C for 24 hours, and then place it in a lyophilizer for 16 hours; freeze-dried scaffolds are cross-linked under vacuum at 105°C for 24 hours; Heparin was added to 0.05M MES (pH5.4) of EDC (20mmmol) and N-hydroxysuccinimide (NHS) at a molar ratio of 2:1 based on a heparin-to-collagen mass ratio of 1:10 solution, and then place the lyophilized scaffold in the mixed solution for cross-linking for 24 hours, and then freeze-lyophilize again after repeated washing to obtain a cross-linked heparinized collagen-chitosan scaffold (for microstructure, see figure 1 ).
[0040] After the heparinized collagen-chitosan scaffold was ste...